ReviewTherapeutics and clinical risk management2023

Status and Future Directions of Therapeutics and Prognosis of Cardiac Amyloidosis.

Wenbing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.